Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor immunobiology is incomplete. While hundreds of im...
Saved in:
Main Authors: | Jeffrey R. Whiteaker, Rachel A. Lundeen, Lei Zhao, Regine M. Schoenherr, Aura Burian, Dongqing Huang, Ulianna Voytovich, Tao Wang, Jacob J. Kennedy, Richard G. Ivey, Chenwei Lin, Oscar D. Murillo, Travis D. Lorentzen, Mathangi Thiagarajan, Simona Colantonio, Tessa W. Caceres, Rhonda R. Roberts, Joseph G. Knotts, Joshua J. Reading, Jan A. Kaczmarczyk, Christopher W. Richardson, Sandra S. Garcia-Buntley, William Bocik, Stephen M. Hewitt, Karen E. Murray, Nhan Do, Mary Brophy, Stephen W. Wilz, Hongbo Yu, Samuel Ajjarapu, Emily Boja, Tara Hiltke, Henry Rodriguez, Amanda G. Paulovich |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2231b7f4bf4c4dfdac9a7d21bf8f78b2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolite Profiling for Six 'B' Vitamins Using LC-MS in Tomato Genotypes at Different Stages of Fruit Maturity
by: P Kavitha, et al.
Published: (2015) -
Rapid implementation of a modular clinical trial informatics solution for COVID-19 research
by: Rupali Dhond, et al.
Published: (2021) -
Refinement of 16S rRNA gene analysis for low biomass biospecimens
by: Remy Villette, et al.
Published: (2021) -
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
by: Nathanael Fillmore, et al.
Published: (2021) -
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study
by: Nathanael Fillmore, et al.
Published: (2021)